131 related articles for article (PubMed ID: 6128867)
1. Prenalterol in the treatment of congestive heart failure developing during beta-blocking therapy. A comparison with frusemide in patients with acute myocardial infarction.
Dahlström U; Karlsson E
Acta Med Scand; 1982; 212(3):125-30. PubMed ID: 6128867
[No Abstract] [Full Text] [Related]
2. Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction.
Nelson GI; Silke B; Ahuja RC; Walker C; Forsyth DR; Verma SP; Taylor SH
Am Heart J; 1984 Jun; 107(6):1202-9. PubMed ID: 6144266
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
Hutton I; Tweddel AC; Bastian BC; Murray RG
Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
[No Abstract] [Full Text] [Related]
4. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.
Glover DR; Wathen CG; Murray RG; Petch MC; Muir AL; Littler WA
Br Heart J; 1985 Feb; 53(2):208-15. PubMed ID: 2857088
[TBL] [Abstract][Full Text] [Related]
5. [Effects of Prenalterol on left ventricular function of coronary patients].
Javernaro A; Bolognesi R; Giacometti P; Potenza D; Cortesi G; Cucchini F
Acta Biomed Ateneo Parmense; 1983; 54(1):17-8. PubMed ID: 6134412
[TBL] [Abstract][Full Text] [Related]
6. The hemodynamic actions of prenalterol in left ventricular failure.
Awan NA; Evenson MK; Needham KE; Mason DT
Acta Med Scand Suppl; 1982; 659():251-61. PubMed ID: 6127893
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarction.
Boström PA; Andersson J; Johansson BW; Lilja B; Thorell J; Tidfält K; Westerling S
Eur J Clin Invest; 1984 Jun; 14(3):175-80. PubMed ID: 6147253
[TBL] [Abstract][Full Text] [Related]
8. Short and long-term effects of hydralazine and combined hydralazine and prenalterol therapy in patients with congestive heart failure.
Drexler H; Löllgen H; Just H
Acta Med Scand Suppl; 1982; 659():315-24. PubMed ID: 6127898
[No Abstract] [Full Text] [Related]
9. Hemodynamic and cardiometabolic effects of prenalterol in patients with acute myocardial infarction and shock.
Reiz S; Friedman A; Häggmark S
Acta Anaesthesiol Scand; 1981 Jun; 25(3):235-9. PubMed ID: 6119869
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy.
Erbel R; Meyer J; Lambertz H; Schweizer P; Voelker W; Krebs W; Braun G; Effert S
Circulation; 1982 Aug; 66(2):361-9. PubMed ID: 6124326
[No Abstract] [Full Text] [Related]
11. In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1982 Jan; 220(1):77-85. PubMed ID: 6118432
[No Abstract] [Full Text] [Related]
12. [Long-term effect of a new beta-agonist prenalterol in patients with severe congestive heart failure (author's transl)].
Lambertz H; Erbel R; Meyer J; Schweizer P; Effert S
Z Kardiol; 1982 Jan; 71(2):65-74. PubMed ID: 6122313
[No Abstract] [Full Text] [Related]
13. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
Tweddel AC; Murray RG; Pearson D; Martin W; Hutton I
Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
[TBL] [Abstract][Full Text] [Related]
14. Clinical experiences with prenalterol as an antidote to Beta-adrenoceptor blockade.
Kulling P
Acta Med Scand Suppl; 1982; 659():191-9. PubMed ID: 6127889
[TBL] [Abstract][Full Text] [Related]
15. Prenalterol in symptomatic sinus node dysfunction.
Feleke E; Rydén L; Smedgård P; Westerling S
Am Heart J; 1985 Jan; 109(1):185-7. PubMed ID: 2857060
[No Abstract] [Full Text] [Related]
16. Prenalterol as long-term therapy for chronic congestive heart failure. A randomized cross-over trial.
Dahlström U; Areskog M; Wranne B; Karlsson E
Acta Med Scand; 1984; 216(2):199-207. PubMed ID: 6149671
[TBL] [Abstract][Full Text] [Related]
17. Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.
Waagstein F; Estrada-Yamamoto M; Reiz S; Reyes C; Hjalmarson A
Acta Med Scand Suppl; 1982; 659():221-31. PubMed ID: 6127891
[TBL] [Abstract][Full Text] [Related]
18. Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man.
Weiss A; Pfister B; Imhof P; Degen PH; Burckhardt D; Dubach UC
Eur J Clin Pharmacol; 1980 Nov; 18(5):383-90. PubMed ID: 6108221
[No Abstract] [Full Text] [Related]
19. Effects of prenalterol administered orally in patients with congestive heart failure.
Hjalmarson A; Abelardo N; Caidahl K; Reyes C; Waagstein F; Wallentin I; Wikstrand J; Estrada-Yamamoto M
Acta Med Scand Suppl; 1982; 659():201-20. PubMed ID: 6127890
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of heart failure with beta adrenoceptor agonists].
Klein G; Wirtzfeld A; Schnelle K
MMW Munch Med Wochenschr; 1983 Apr; 125(14):277-80. PubMed ID: 6134232
[No Abstract] [Full Text] [Related]
[Next] [New Search]